Lento Bio

Lento Bio is a biotechnology and pharmaceutical startup founded in 2022 with the slogan "Restoring Tissue Flexibility and Function in Chronic Diseases of Aging." The company's focus is on developing effective, safe, and durable treatments for chronic age-related diseases. It was formed in partnership with Ichor Life Sciences, leveraging their expertise to directly target molecular damage using small molecules. Lento Bio's headquarters is located in the United States. As of now, details regarding the last investment and the involved investors are not available. However, with its promising mission and strategic partnership, Lento Bio presents itself as an intriguing prospect for potential venture capital investment. The innovative approach to address age-related diseases through molecular targeting aligns with the growing demand for advancements in the biotechnology and pharmaceutical industries. As the startup continues to progress in its research and development efforts, it may attract substantial attention from venture capital firms seeking investment opportunities in groundbreaking healthcare solutions.